genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Antibodies
In Race to Supply Smallest Antibodies, Cows Outpace Camelids
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Cancer
Researchers Keep Cancer Cells Out by Blocking the Gate to the…
Alzheimers
Alzheimer’s Epigenetic Drivers Identified
Insights
All
Trends for 2020
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Bioprocessing
Observing the Performance of Planova Filters
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibodies
In Race to Supply Smallest Antibodies, Cows Outpace Camelids
eBooks
The Future of Drug Discovery
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Renal Cancer
Renal Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Renal Cancer
Researchers Discover Key Structures in Kidney Formation
Renal Cancer
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding Late-Stage Kidney Cancer Candidate
Renal Cancer
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Renal Cancer
Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy into the Clinic
Renal Cancer
Acceleron Halts Development of Cancer Candidate Dalantercept
Renal Cancer
New Mouse Model Developed for Investigating Kidney Cancer
Renal Cancer
Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers
Renal Cancer
Argos Says Lead Candidate Likely to Fail Phase III Trial
Renal Cancer
After RCC Trial Failure, Cerulean to Slash Headcount
Renal Cancer
AVEO Oncology Awards European Rights to Tivozanib for Up to $396.5M+
Renal Cancer
GSK, Idera Partner on Third-Gen Antisense Drugs for Renal Disease
Renal Cancer
AstraZeneca, Isis Pharma Expand Antisense Collaboration
Renal Cancer
FDA Rejects Aveo’s Tivozanib for RCC; Rips Phase III Results
Renal Cancer
Pfizer Drug Disappoints in Treatment-Naive RCC Study
Renal Cancer
New Data Released for Tivozanib Against RCC
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
